Cue Biopharma, Inc. Active Patents
32 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-01-15: Application 19022291; Invention T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof; Applicant Cue Biopharma, Inc.; Status Patented Case.
- 2023-12-22: Application 18395042; Invention MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF; Applicant Cue Biopharma, Inc.; Status Patented Case.
- 2023-12-20: Application 18391486; Invention T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF; Applicant Cue Biopharma, Inc.; Status Patented Case.
- 2023-11-16: Application 18511502; Invention MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF; Applicant Cue Biopharma, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | 19022291 | T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof | Cue Biopharma, Inc. | Patented Case | 2025-09-23 | 12421287 | US20250243253A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2023-12-22 | 18395042 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2025-03-25 | 12257311 | US20240252663A1 | Saso Cemerski Ronald D. Seidel III Rodolfo J. Chaparro John F. Ross | United States United States United States United States | PAK, MICHAEL D |
| 2023-12-20 | 18391486 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-12-31 | 12180258 | US20240199715A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2023-11-16 | 18511502 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2025-12-02 | 12485184 | US20240189437A1 | Saso Cemerski Ronald D. Seidel III Rodolfo J. Chaparro John F. Ross | United States United States United States United States | PAK, MICHAEL D |
| 2023-11-10 | 18388792 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-05-21 | 11987610 | US20240083964A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2023-11-10 | 18388788 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-11-19 | 12145973 | US20240076344A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2023-08-24 | 18237718 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-11-26 | 12152061 | US20240141006A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2023-07-27 | 18227057 | METHODS FOR MODULATING AN IMMUNE RESPONSE | Cue Biopharma, Inc. | Patented Case | 2024-05-28 | 11993641 | US20230374102A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | XIAO, YAN |
| 2023-07-06 | 18218943 | MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-07-09 | 12029782 | US20230346900A1 | Ronald D. Seidel III Rodolfo J. Chaparro John F. Ross Chee Meng Low | United States United States United States United States | JUEDES, AMY E |
| 2023-06-14 | 18334911 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-01-23 | 11878062 | US20230390407A1 | Saso Cemerski Ronald D. Seidel III Rodolfo J. Chaparro John F. Ross | United States United States United States United States | PAK, MICHAEL D |
| 2023-05-26 | 18202596 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2024-02-20 | 11905320 | US20230399372A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2023-04-12 | 18134016 | TGF-Beta Polypeptides | Cue Biopharma, Inc. | Patented Case | 2026-01-20 | 12528850 | US20230416322A1 | Ronald D. SEIDEL III Rodolfo J. CHAPARRO John F. ROSS Chee Meng LOW | United States United States United States United States | MERTZ, PREMA MARIA |
| 2022-12-13 | 18080275 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2023-12-26 | 11851467 | US20230257439A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2022-10-06 | 17961005 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2023-08-29 | 11739133 | US20230220032A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2022-10-06 | 17961001 | METHODS FOR MODULATING AN IMMUNE RESPONSE | Cue Biopharma, Inc. | Patented Case | 2023-09-26 | 11767355 | US20230109980A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | XIAO, YAN |
| 2022-08-31 | 17900636 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2025-12-02 | 12485183 | US20230139456A1 | Saso Cemerski Ronald D. Seidel III Rodolfo J. Chaparro John F. Ross | United States United States United States United States | PAK, MICHAEL D |
| 2022-06-21 | 17845583 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2023-07-25 | 11708400 | US20220356224A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2022-06-02 | 17831024 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2022-12-20 | 11530248 | US20220340632A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2022-05-20 | 17749973 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2022-11-22 | 11505588 | US20220289808A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2022-04-16 | 17722328 | TGF-Beta Polypeptides | Cue Biopharma, Inc. | Patented Case | 2023-07-04 | 11692018 | US20220372093A1 | Ronald D. SEIDEL III Rodolfo J. CHAPARRO John F. ROSS Chee Meng LOW | United States United States United States United States | MERTZ, PREMA MARIA |
| 2022-01-18 | 17578094 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2022-07-05 | 11377478 | US20220177536A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2021-10-21 | 17507113 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2022-06-28 | 11370821 | US20220033456A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2021-07-21 | 17381858 | METHODS FOR MODULATING AN IMMUNE RESPONSE | Cue Biopharma, Inc. | Patented Case | 2024-04-16 | 11958893 | US20220089681A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | XIAO, YAN |
| 2021-02-19 | 17180064 | METHODS FOR MODULATING AN IMMUNE RESPONSE | Cue Biopharma, Inc. | Patented Case | 2021-08-31 | 11104712 | US20210206830A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | XIAO, YAN |
| 2021-02-16 | 17176777 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2021-09-14 | 11117945 | US20210198337A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2020-07-07 | 16922697 | METHODS FOR MODULATING AN IMMUNE RESPONSE | Cue Biopharma, Inc. | Patented Case | 2021-02-23 | 10927161 | US20200331982A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | XIAO, YAN |
| 2020-06-23 | 16909323 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES COMPRISING REDUCED-AFFINITY IMMUNOMODULATORY POLYPEPTIDES | Cue Biopharma, Inc. | Patented Case | 2023-07-18 | 11702461 | US20200317747A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | KINSEY WHITE, NICOLE ERIN |
| 2020-03-26 | 16830831 | METHODS FOR MODULATING AN IMMUNE RESPONSE | Cue Biopharma, Inc. | Patented Case | 2022-10-25 | 11479595 | US20200325205A1 | Ronald D. Seidel III Rodolfo J. Chaparro | United States United States | XIAO, YAN |
| 2020-03-09 | 16812926 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2021-02-23 | 10927158 | US20200199181A1 | Ronald D. Seidel III Rodolfo Chaparro | United States United States | BOESEN, AGNIESZKA |
| 2020-03-06 | 16812125 | T-Cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use Thereof | Cue Biopharma, Inc. | Patented Case | 2024-06-11 | 12006348 | US20200369745A1 | Ronald D. SEIDEL III Rodolfo J. CHAPARRO John F. ROSS Chee Meng LOW | United States United States United States United States | WANG, RUIXUE |
| 2019-06-25 | 16473576 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2023-12-26 | 11851471 | US20200140519A1 | Ronald D. Seidel III Rodolfo Chaparro | United States United States | LU, CHENG |
| 2018-09-27 | 16089335 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | Patented Case | 2022-11-22 | 11505591 | US20190106476A1 | Ronald D. Seidel III Rodolfo Chaparro | United States United States | OUSPENSKI, ILIA I |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |